These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2175623)

  • 1. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?
    Lees KR; MacFadyen RJ; Reid JL
    Am J Hypertens; 1990 Nov; 3(11):266S-272S. PubMed ID: 2175623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management.
    Reams GP
    Am J Cardiol; 1992 Apr; 69(10):59C-64C. PubMed ID: 1312296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition in the tissues.
    Unger T; Gohlke P
    Clin Physiol Biochem; 1992; 9(3):89-93. PubMed ID: 1338777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
    Hunley TE; Tamura M; Stoneking BJ; Nishimura H; Ichiki T; Inagami T; Kon V
    Kidney Int; 2000 Feb; 57(2):570-7. PubMed ID: 10652034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors: future perspectives.
    Reid JL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S41-3. PubMed ID: 7507539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition.
    Brito PL; Dos Santos AF; Chweih H; Favero ME; Gotardo EMF; Silva JAF; Leonardo FC; Franco-Penteado CF; de Oliveira MG; Ferreira WA; Zaidan BC; Billis A; Baldanzi G; Mashima DA; Antunes E; Saad STO; Costa FF; Conran N
    PLoS One; 2022; 17(2):e0263424. PubMed ID: 35113975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
    Lee MA; Paul M; Böhm M; Ganten D
    Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.